Lung Cancer
Volume 55, Issue 1 , Pages 25-34, January 2007

Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms

  • Odilia Popanda

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Fax: +49 6221 42 3359.
  • ,
  • Lutz Edler

      Affiliations

    • Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • ,
  • Peter Waas

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
  • ,
  • Torsten Schattenberg

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
  • ,
  • Dorota Butkiewicz

      Affiliations

    • Department of Tumor Biology, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Gliwice, Poland
  • ,
  • Thomas Muley

      Affiliations

    • Thoraxklinik am Universitätsklinikum Heidelberg, Germany
  • ,
  • Hendrik Dienemann

      Affiliations

    • Thoraxklinik am Universitätsklinikum Heidelberg, Germany
  • ,
  • Angela Risch

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
  • ,
  • Helmut Bartsch

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
  • ,
  • Peter Schmezer

      Affiliations

    • Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

Received 11 July 2006; received in revised form 7 September 2006; accepted 14 September 2006.

Summary 

Alterations in cell cycle regulation and apoptosis leading to malignant transformation could be caused by common genetic variants in tumor suppressor genes. The effects of the TP53 polymorphism Arg72Pro on lung cancer risk have been investigated in numerous studies with, however, conflicting results. In many studies, important risk modifiers such as smoking or tumor histology were not taken into account. We therefore investigated the combined effects of polymorphisms in TP53 (Arg72Pro) and p21/CDKN1A (Ser31Arg) and smoking on lung cancer risk. Our case–control study consisted of 405 patients with lung cancer, mainly squamous-cell carcinoma (185) and adenocarcinoma (177) and 404 unmatched tumor-free hospital controls. Multivariate regression analysis showed a moderate but statistically significant risk of lung cancer overall and especially of squamous-cell carcinoma (OR, 1.65; CI, 1.10–2.47) for TP53 72Pro allele carriers. The risk was markedly increased in heavy smokers (>20 pack-years) with squamous-cell carcinoma (OR, 2.80 in patients homozygous for 72Pro; CI, 1.19–6.58), but not in light smokers (≤20 pack-years). The results for the p21 Ser31Arg polymorphism suggested that 31Ser is a moderate-risk allele for squamous-cell carcinoma. Analysis of the combined effects of the two polymorphisms revealed a higher OR for TP53 72Pro carriers homozygous for p21 31Ser than for 72Pro carriers in general; this effect being most pronounced in heavy smokers with squamous-cell carcinoma (OR, 3.84; CI, 1.46–10.1). Our data indicate that the TP53 Arg72Pro polymorphism increases the risk for squamous-cell carcinoma mainly in heavy smokers. The observed interaction with smoking is biologically plausible as, for the 72Pro p53 variant, decreased apoptosis and extended G1 cell cycle arrest is reported after carcinogen exposure. Nevertheless, confirmation by further molecular and epidemiological studies is warranted.

Abbreviations: p21, CDKN1A (Waf1, cip1), SCC, squamous-cell carcinoma, OR, odds ratio, CI, confidence interval

Keywords: Cell cycle control, Molecular epidemiology, Genotype, Adenocarcinoma of the lung, DNA repair

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(06)00485-5

doi:10.1016/j.lungcan.2006.09.006

Lung Cancer
Volume 55, Issue 1 , Pages 25-34, January 2007